PHILADELPHIA and OXFORD, March 2, 2021 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device ...
SHANGHAI, June 17, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science ...
SHANGHAI, Nov. 11, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science ...
SHANGHAI, July 10, 2025 /PRNewswire/ -- WuXi AppTec Co., Ltd. (stock code: 603259.SH/2359.HK), a leading global pharmaceutical and life sciences technology platform company offering integrated, end-to ...
With the BIOSECURE Act on the verge of passage and bringing with it the threat of crippling the business of four Chinese companies, the largest of the group, manufacturing powerhouse WuXi AppTec has ...
As WuXi AppTec awaits being relisted on the Chinese stock market, it hasn’t halted expansions. The Shanghai-based biopharma research enabler has acquired U.S.-based CRO ResearchPoint Global (RPG).
Plus ça change . . . In 2004, C&EN ran an article on WuXi AppTec (then called WuXi PharmaTech) that opened with the observation that change at the firm had been dizzying since it was founded in 2000.
LAVAL, Quebec--(BUSINESS WIRE)--Altasciences, a mid-size CRO specializing in a flexible, innovative approach to providing comprehensive early stage drug development from lead candidate selection to ...
(Bloomberg) -- WuXi AppTec Co. tumbled after a US Senate committee advanced a bill that may ban Chinese biotech firms from accessing federal contracts and largely cut off the biopharmaceutical company ...
SHANGHAI, Sept. 5, 2021 /PRNewswire/ -- WuXi AppTec ("the Company") is pleased to announce that Morgan Stanley Capital International ("MSCI") has upgraded its MSCI ...
WuXi AppTec is seeking an IPO for its drug R&D businesses on China’s common stock market, a move that confirmed buzz that the CRO giant would re-enlist its businesses in three pieces. The company made ...
(Bloomberg) -- WuXi AppTec Co. tumbled by an intraday record in Hong Kong, with traders attributing the decline to proposed US legislation that would ban the Chinese medical technology company and its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results